The science of pterygia

British Journal of Ophthalmology

Volumn 94, Issue 7, 2010, Pages 815-820

  Bradley, Jay C ^a,b   Yang, W ^b   Bradley, R H ^b   Reid, T W ^b   Schwab, I R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ANGIOGENESIS; ARTICLE; CELL CYCLE REGULATION; CHOLESTEROL METABOLISM; EXTRACELLULAR MATRIX; HEREDITY; HUMAN; NEOVASCULARIZATION (PATHOLOGY); OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PTERYGIUM; RADIATION EXPOSURE; SURGICAL APPROACH; ULTRAVIOLET B RADIATION; VIRUS INFECTION;

CELL CYCLE; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HUMANS; INFLAMMATION MEDIATORS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PTERYGIUM; RECURRENCE; ULTRAVIOLET RAYS;

EID: 77954302504     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.151852     Document Type: Article

References (96)

1. Di Girolamo N, Chui J, Coroneo MT, et al. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004;23:195-228.
2. Chui J, Di Girolamo N, Wakefield D, et al. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf 2008;6:24-43.
3. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol 1999;6:219-28. (Pubitemid 29500452)
4. Kau HC, Tsai CC, Lee CF, et al. Increased oxidative DNA damage, 8-hydroxydeoxyguanosine, in human pterygium. Eye 2006;20:826-31.
5. Tsai YY, Cheng YW, Lee H, et al. Oxidative DNA damage in pterygium. Mol Vis 2005;11:71-5.
6. Perra MT, Maxia C, Corbu A, et al. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine. Mol Vis 2006;12:1136-42.
7. Kau HC, Tsai CC, Hsu WM, et al. Genetic polymorphism of hOGG1 and risk of pterygium in Chinese. Eye 2004;18:635-9.
8. Tsai YY, lee H, Tseng SH, et al. Null type of glutathione S-transferase M1 polymorphism is associated with early onset pterygium. Mol Vis 2004;10:458-61.
9. Wang IJ, Lai WT, Liou SW, et al. Impression cytology of pterygium. J Ocul Pharmacol Ther 2000;16:519-28.
10. Tan DT, Tang WY, Liu YP, et al. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000;84:212-6.
11. Maxia C, Perra MT, Demurtas P, et al. Expression of survivin protein in pterygium and relationship with oxidative DNA damage. J Cell Mol Med 2008;12:2372-80.
12. Dushku N, Hatcher SL, Albert DM, et al. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol 1999;117:1593-9.
13. Tan DT, Lim AS, Goh HS, et al. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997;123:404-5.
14. Weinstein O, Rosenthal G, Zirkin H, et al. Overexpression of p53 tumor suppressor gene in pterygia. Eye 2002;16:619-21.
15. Dushku N, Reid TW. p53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997;16:1179-92. (Pubitemid 27515671)
16. Ueda Y, Kanazawa S, Kitaoka T, et al. Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem 2001;103:159-65. (Pubitemid 32385675)
17. Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in pterygium. Cancer Lett 2004;206:77-83.
18. Tsai YY, Cheng YW, Lee H, et al. p53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis 2005;11:50-5.
19. Ashcroft M, Vousden KH. Regulation of p53 stability. Oncogene 1999;18:7637-43.
20. Schneider BG, John-Aryankalayil M, Rowsey JJ, et al. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. Exp Eye Res 2006;82:91-8.
21. Tsai YY, Chang KC, Lee H, et al. Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium. Clin Experiment Ophthalmol 2005;33:60-2.
22. Tsai YY, Cheng YW, Lee H, et al. No association of p53 codon 72 and p21 codon 31 polymorphisms in Taiwan Chinese patients with pterygium. Br J Ophthalmol 2004;88:975-6.
23. Sakoonwatanyoo P, Tan DT, Smith DR. Expression of p63 in pterygium and normal conjunctiva. Cornea 2004;23:67-70.
24. Chen PL, Cheng YW, Chiang CC, et al. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b. Mol Vis 2006;12:1411-16.
25. Tong L. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 2008;92:157.
26. Kase S, Takahashi S, Sato I, et al. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 2007;91:958-61.
27. Tsai YY, Bau DT, Chiang CC, et al. Pterygium and genetic polymorphism of DNA double strand break repair gene Ku70. Mol Vis 2007;13:1436-40.
28. Detorakis ET, Zafiropoulos A, Arvanitis DA, et al. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia. Eye 2005;19:210-14.
29. Shimmura S, Ishioka M, Hanada K, et al. Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci 2000;41:1364-9. (Pubitemid 30261858)
30. Detorakis ET, Sourvinos G, Tsamparlakis J, et al. Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol 1998;82:1324-8. (Pubitemid 28524132)
31. Chen JK, Tsai RJ, Lin SS. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol Anim 1994;30A:243-8.
32. Detorakis ET, Drakonaki EE, Spandidos DA. Molecular genetic alterations and viral presence in ophthalmic pterygium. Int J Mol Med 2000;6:35-41.
33. Schneider BG, Sahni D, Torres JC, et al. MLH1 and MSH2 expression in pterygia. Cornea 2007;26:468-72.
34. Di Girolamo N, Kumar RK, Coroneo MT, et al. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002;43:3430-7. (Pubitemid 35334350)
35. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 1998;236:702-8.
36. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta, and tumor necrosis factor-alpha in pterygium. Acta Histochem 1996;98:195-201.
37. Chiang CC, Cheng YW, Lin CL, et al. Cyclooxygenase 2 expression in pterygium. Mol Vis 2007;13:635-8.
38. Tong L, Li J, Chew J, et al. Phospholipase D in the human ocular surface and in pterygium. Cornea 2008;27:693-8.
39. Beden U, Irkec M, Orhan D, et al. The roles of T-lymphocyte subpopulations (CD4 and CD8), intercellular adhesion molecule-1 (ICAM-1), HLA-DR receptor, and mast cells in etiopathogenesis of pterygium. Ocul Immunol Inflamm 2003;11:115-22.
40. Ioachim-Velogianni E, Tsironi E, Agnantis N, et al. HLA-DR expression in pterygium epithelial cells and lymphocyte subpopulations: an immunohistochemistry study. Ger J Ophthalmol 1995;4:123-9.
41. Kase S, Osaki M, Sato I, et al. Immunolocalisation of E-cadherin and beta-catenin in human pterygium. Br J Ophthalmol 2007;91:1209-12.
42. Kato N, Shimmura S, Kawakita T, et al. Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium. Invest Ophthalmol Vis Sci 2007;48:1511-7.
43. Ribatti D, Nico B, Maxia C, et al. Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 2007;11:585-9.
44. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984;98:225-8.
45. Liu L, Yang D. Immunological studies on the pathogenesis of pterygium. Chin Med Sci J 1993;8:84-8.
46. John-Aryankalayil M, Dushku N, Jaworski CJ, et al. Microarray and protein analysis of human pterygium. Mol Vis 2006;12:55-64.
47. Nolan TM, Di Girolamo N, Coroneo MT, et al. Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts. Invest Ophthalmol Vis Sci 2004;45:110-13.
48. Jin J, Guan M, Sima J, et al. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea 2003;22:473-7.
49. van Setten G, Aspiotis M, Blalock TD, et al. Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor - possible contributing factor to conjunctival scarring. Graefes Arch Clin Exp Ophthalmol 2003;241:135-9. (Pubitemid 36747801)
50. Solomon A, Grueterich M, Li DQ, et al. Overexpression of Insulin-like growth factor-binding protein-2 in pterygium body fibroblasts. Invest Ophthalmol Vis Sci 2003;44:573-80.
51. Wong YW, Chew J, Yang H, et al. Expression of insulin-like growth factor binding protein-3 in pterygium tissue. Br J Ophthalmol 2006;90:769-72.
52. Maini R, Collison DJ, Maidment JM, et al. Pterygial derived fibroblasts express functionally active histamine and epidermal growth factor receptors. Exp Eye Res 2002;74:237-44.
53. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999;10:282-8.
54. Nakagami T, Watanabe I, Murakami A, et al. Expression of stem cell factor in pterygium. Jpn J Ophthalmol 2000;44:193-7.
55. Di Girolamo N, Wakefield D, Coroneo MT. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006;47:2430-7.
56. Nolan TM, DiGirolamo N, Sachdev NH, et al. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am J Pathol 2003;162:567-74. (Pubitemid 36267863)
57. Tsai YY, Chiang CC, Bau DT, et al. Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients. Cornea 2008;27:476-9.
58. Hong S, Choi JY, Lee HK, et al. Expression of neurotrophic factors in human primary pterygeal tissue and selective TNF-alpha induced stimulation of ciliary neurotrophic factor in pterygeal fibroblasts. Exp Toxicol Pathol 2008;60:513-20.
59. Aspiotis M, Tsanou E, Gorezis S, et al. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye 2007;21:1095-101.
60. Marcovich AL, Morad Y, Sandbank J, et al. Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res 2002;25:17-22.
61. Chui J, Di Girolamo N, Coroneo MT, et al. The role of substance P in the pathogenesis of pterygia. Invest Ophthalmol Vis Sci 2007;48:4482-9.
62. Naib-Majani W, Breipohl W, Shazli EE, et al. The Ets-1 transcription factor is involved in pterygial angiogenesis. Anat Histol Embryol 2007;36:107-10.
63. Lee DH, Cho HJ, Kim JT, et al. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 2001;20:738-42.
64. Kase S, Osaki M, Jin XH, et al. Increased expression of erythropoietin receptor in human pterygial tissues. Int J Mol Med 2007;20:699-702.
65. Di Girolamo N, Coroneo MT, Wakefield D. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci 2003;44:4705-14.
66. Di Girolamo N, Coroneo M, Wakefield D. Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol 2005;167:489-503. (Pubitemid 43026104)
67. Wang IJ, Hu FR, Chen PJ, et al. Mechanism of abnormal elastin gene expression in the pinguecular part of pterygia. Am J Pathol 2000;157:1269-76.
68. Naib-Majani W, Eltohami I, Wernert N, et al. Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study. Graefes Arch Clin Exp Ophthalmol 2004;242:332-8.
69. Austin P, Jakobiec FA, Iwamoto T. Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology 1983;90:96-109. (Pubitemid 13175782)
70. Touhami A, Di Pascuale MA, Kawatika T, et al. Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia. Br J Ophthalmol 2005;89:269-74.
71. Lee JK, Song YS, Ha HS, et al. Endothelial progenitor cells in pterygium pathogenesis. Eye 2007;21:1186-93.
72. Ye J, Song YS, Kang SH, et al. Involvement of bone marrow-derived stem and progenitor cells in the pathogenesis of pterygium. Eye 2004;18:839-43.
73. Di Girolamo N, Wakefield D, Coroneo MT. Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head. Invest Ophthalmol Vis Sci 2000;41:4142-9.
74. Dushku N, John MK, Schultz GS, et al. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 2001;119:695-706.
75. Liu YP, Schultz GS, Ren XO, et al. MMP-2 and MMP-9 levels in pterygia and matched superior conjunctiva by gelatin zymography. Invest Ophthalmol Vis Sci 1998;39:S756.
76. Li DQ, Lee SB, Gunja-Smith Z, et al. Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol 2001;119:71-80.
77. Solomon A, Li DQ, Lee SB, et al. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines. Invest Ophthalmol Vis Sci 2000;41:2154-63. (Pubitemid 30450987)
78. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci 2001;42:1963-8. (Pubitemid 32726025)
79. Peiretti E, Dessi S, Putzolu M, et al. Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary pterygium. Invest Ophthalmol Vis Sci 2004;45:3982-5.
80. Peiretti E, Dessi S, Mulas MF, et al. Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics. Exp Eye Res 2006;83:536-42.
81. Peiretti E, Dessi S, Mulas C, et al. Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. Invest Ophthalmol Vis Sci 2007;48:3450-8.
82. Gallagher MJ, Giannoudis A, Herrington CS, et al. Human papillomavirus in pterygium. Br J Ophthalmol 2001;85:782-4.
83. Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea 2001;20:164-7.
84. Sjo NC, von Buchwald C, Prause JU, et al. Human papillomavirus and pterygium. Is the virus a risk factor? Br J Ophthalmol 2007;91:1016-8.
85. Chen KH, Hsu WM, Cheng CC, et al. Lack of human papillomavirus in pterygium of Chinese patients from Taiwan. Br J Ophthalmol 2003;87:1046-8.
86. Piras F, Moore PS, Ugalde J, et al. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol 2003;87:864-6.
87. Reid TW, Dushku N. Does human papillomavirus cause pterygium? Br J Ophthalmol 2003;87:806-8.
88. Chowers I, Pe'er J, Zamir E, et al. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001;108:985-8.
89. Kuo CH, Miyazaki D, Nawata N, et al. Prognosis-determinant candidate genes identified by whole genome scanning in eyes with pterygia. Invest Ophthalmol Vis Sci 2007;48:3566-75.
90. Li W, Chen YT, Hayashida Y, et al. Down-regulation of Pax-6 is associated with abnormal differentiation of corneal epithelial cells in severe ocular surface diseases. J Pathol 2008;214:114-22.
91. Tan DT, Liu YP, Sun L. Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci 2000;41:1684-6. (Pubitemid 30354337)
92. Karukonda SR, Thompson HW, Beuerman RW, et al. Cell cycle kinetics in pterygium at three latitudes. Br J Ophthalmol 1995;79:313-7.
93. Reid TW, Dushku N. Pterygia and limbal epithelial cells: relationship and molecular mechanisms. Prog Retin Eye Res 1996;15:297-329.
94. Coroneo MT. Albedo concentration in the anterior eye: a phenomenon that locates some solar diseases. Ophthalmic Surg 1990;21:60-6.
95. Ooi JL, Sharma NS, Papalkar D, et al. Ultraviolet fluorescence photography to detect early sun damage in the eyes of school-aged children. Am J Ophthalmol 2006;141:294-8.
96. Ooi JL, Sharma NS, Sharma S, et al. Ultraviolet fluorescence photography: patterns in established pterygia. Am J Ophthalmol 2007;143:97-101.